Cargando…
Identification of H(2)S/NO-donating artemisinin derivatives as potential antileukemic agents
Three H(2)S/NO-donating artemisinin derivatives were designed and synthesized. Their antiproliferative activities were evaluated against human acute myeloid leukemia (AML) cell lines of K562 and K562/ADR and human normal liver cells of LO2. Biological evaluation indicated that NO-donating compound 1...
Autores principales: | Chen, Xuemei, Huang, Pei, Wang, Jing, Tian, Runmei, Chen, Yan, Chen, Yongzheng, Zhang, Lei, Ma, Zhigui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047252/ https://www.ncbi.nlm.nih.gov/pubmed/35492518 http://dx.doi.org/10.1039/c9ra08239e |
Ejemplares similares
-
Design, synthesis and biological evaluation of novel nitric oxide-donating podophyllotoxin derivatives as potential antiproliferative agents against multi-drug resistant leukemia cells
por: Zhang, Lei, et al.
Publicado: (2018) -
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
por: Fox, Jennifer M., et al.
Publicado: (2016) -
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology
por: Kagan, Amanda B., et al.
Publicado: (2022) -
Antileukemic activity of novel adenosine derivatives
por: Poczta, Anastazja, et al.
Publicado: (2019) -
Correction: Chrysomycins A–C, antileukemic naphthocoumarins from Streptomyces sporoverrucosus
por: Jain, Shreyans K., et al.
Publicado: (2022)